Pentwater Capital Management’s Cardiovascular Systems CSII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-1,744,819
Closed -$34.7M – 175
2023
Q1
$34.7M Buy
+1,744,819
New +$30.1M 0.34% 51
2020
Q4
– Sell
-44,977
Closed -$1.77M – 275
2020
Q3
$1.77M Sell
44,977
-5,023
-10% -$162K 0.02% 128
2020
Q2
$1.58M Buy
+50,000
New +$1.87M 0.03% 88

Other funds holding CSII

Pentwater Capital Management's CSII Position: Q2 2023 in Review

Pentwater Capital Management sold out of Cardiovascular Systems (CSII) in Q2 2023, closing a stake of 1,744,819 shares — an estimated $34.7M sold.

Pentwater Capital Management first reported a position in CSII in Q2 2020 and held it in 3 quarters. The position peaked at $34.7M in Q1 2023. 2 funds tracked by Wall St. Rank hold CSII as of Q2 2023.

  • Pentwater Capital Management reported no remaining Cardiovascular Systems position as of Q2 2023 after selling out during the quarter.
  • Pentwater Capital Management sold 1,744,819 Cardiovascular Systems shares in Q2 2023, an estimated $34.7M.
  • Pentwater Capital Management first reported a position in Cardiovascular Systems in Q2 2020 and held it in 3 quarters.
  • Pentwater Capital Management's Cardiovascular Systems position peaked at $34.7M in Q1 2023.
  • 2 funds tracked by Wall St. Rank held Cardiovascular Systems as of Q2 2023.

Based on Pentwater Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.